| Code | CSB-MP025833HU-WD1 |
| Abbreviation | Recombinant Human VEGF165 protein (Active) |
| MSDS | |
| Size | Inquiry |
| Order now | |
| Image | |
| Have Questions? | Leave a Message or Start an on-line Chat |
VEGF165 drives endothelial cell proliferation and angiogenesis through high-affinity binding to VEGFR-2, making it a central mediator in both physiological vascularization and tumor neovascularization studies. This recombinant protein, spanning the complete mature sequence (aa 27–191), demonstrates potent mitogenic activity in HUVEC proliferation assays with an ED50 of 0.2–5 ng/mL, providing a quantitative benchmark for dose-response experiments in angiogenesis models and wound healing assays. Mammalian expression preserves native glycosylation and disulfide architecture, supporting accurate receptor-ligand binding studies by surface plasmon resonance, competition ELISA, and antibody epitope mapping where post-translational fidelity is critical. The protein meets the purity and endotoxin criteria typical for in vivo regenerative medicine models and tumor biology experiments, with >95% purity by SDS-PAGE and ≤10 EU/mg endotoxin, ensuring minimal interference in sensitive primary cell cultures and animal studies.
There are currently no reviews for this product.